Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Post by SamV21on Jan 18, 2022 12:58am
334 Views
Post# 34327144

Qixleef not past Phase 2 , 100,000s of millions still needed

Qixleef not past Phase 2 , 100,000s of millions still neededWhere do you keep getting this idea that Qixleef is worth anything at Phase 2 , please show us any other drug that was worth anything at Phase 2 .You are just empty promoting  on nothing.It could take another 500,000,000 to get Qixleef to market where is that money going to come from? Tetra is estimating/guessing  income from Qixleef not till 2027 ,Qixleef will not grab attention unless it gets to the end of Phase 3 , the maybe , but Tetra will run out of money before then so  put your frigen pom poms away about Qixleef already.You said Tetra was cheap at .30 cents and then at .25 and crazy cheap at .20 cents and once again at .13 are you related to Guy scammer or something ?I am going to repost this message  when we hit .09 . 
<< Previous
Bullboard Posts
Next >>